Mohammed AlSheef

Dr. Mohammed AlSheef


Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2020 in BioMed Research International
Verified
Journal Article
Open access
PDF file
MAMohammed AlSheef
Mohammed AlSheef
AAAlhanouf M Alabbad
Alhanouf M Alabbad
RARowida A Albassam
Rowida A Albassam
RARawan M Alarfaj
Rawan M Alarfaj
Abdul Rehman Zia ZaidiAbdul Rehman Zia Zaidi
Abdul Rehman Zia Zaidi
AAAmani Abu-Shaheen
Amani Abu-Shaheen
Background. Pregnancy is one of the major risk factors for the development of venous thromboembolism (VTE). Objective. To elucidate the circumstances surrounding pregnancy‐induced deep vein thrombosis (DVT) and pulmonary embolism (PE), assess potential factors triggering thrombosis (e.g., thrombophilia, obesity, age, parity, and family history), initial and long‐term management, and assess recurrence rate and mortality for VTE in pregnant Saudi women. Methods. A retrospective chart review of 180 patients with objectively confirmed VTE (DVT, PE, or both) that occurred during pregnancy, or the postpartum period was conducted. All patients who experienced episodes of objectively confirmed VTE were included. Results. Overall, 180 patients were included. Further, 60% (n = 109) and 40% (n = 71) of the VTE cases occurred during the postpartum and antenatal periods, respectively. Cesarean section was the most prevalent risk factor among study participants (n = 86 (47.8%)), followed by obesity (n = 73 (40.6%)). The most common clinical presentations were lower leg pain (57.2%) and lower limb swelling (54.4%). VTE recurrences were observed in approximately 11% of the participants, and maternal mortality occurred in 2 (1.1%) cases. Conclusion. Pregnancy was the most common provoking factor for VTE in our study. Pregnant women should undergo formal, written assessments of risk factors for VTE at the first visit and delivery. Larger studies with a randomized design, and control groups are required to confirm the current findings.

1 March 2022 in Annals of Medicine & Surgery
Verified
Journal Article
Open access
FAFouad Alshammari
Fouad Alshammari
YAYacoub Abuzied
Yacoub Abuzied
AKAbdulrahman Korairi
Abdulrahman Korairi
MAMohammed Alajlan
Mohammed Alajlan
MAMohammed Alzomia
Mohammed Alzomia
MAMohammed AlSheef
Mohammed AlSheef
Messenger RNA vaccines, commonly known as mRNA vaccines, are the first COVID-19 vaccines that have been authorized and licensed in the United States. Two mRNA vaccines, BNT162b2 (Pfizer-BioNTech) and mRNA-1273 (Moderna) are available. Mass vaccination remains the most critical way to halt the spread of the COVID pandemic. The most common adverse effects of the COVID vaccines are headache, muscular soreness, weariness, redness, swelling, and tenderness at the injection site. The dermatological adverse effects of mRNA vaccines, on the other hand, are little understood. We present a case of bullous fixed medication eruption following delivery of the second dose of Pfizer's Covid-19 vaccination. We discuss the case of a 78-year-old man who went to the Emergency Department at King Fahad Medical City in Riyadh, Saudi Arabia, with numerous bullae throughout his extremities one day after receiving the second dosage of Pfizer Covid-19 vaccine. The bullae began three days before his presentation, and they were preceded by intense pruritus and urticated plaques. A skin biopsy was performed which revealed IgG (+1), IgM (+1), and C3 (+1) staining of the basement membrane. Another punch skin biopsy taken from an intact bulla was suboptimal compressing of dermal tissue only, revealing modest perivascular lymphocytic infiltrative and scattered eosinophils. This pathological picture with superficial perivascular inflammatory dermatitis, and the presence of eosinophils suggests drug-induced bullous pemphigoid. The patient was treated with topical and systemic corticosteroids, fusidic acid cream, and emollients after a confirmed diagnosis of bullous pemphigoid was obtained. He was hospitalized for 3 weeks as a case of severe sepsis due to a skin infection, and he was started initially on empiric antibiotics with piperacillin-tazobactam plus vancomycin that was later upgraded to meropenem and vancomycin based on the results of the blood and wound cultures. The patient suffered a pulmonary embolism on the second day of hospitalization and was placed on a heparin infusion that could potentially contribute to his death one month after discharge from our hospital. Bullous pemphigoid is the most frequent autoimmune bullous disease. It occurs in the elderly. The cause of this disease is unknown, although it sometimes can be triggered by taking certain medications. Two case reports have also revealed bullous pemphigoid eruption following immunization. One case report reported a 78-year-old lady with diabetes and Alzheimer's disease who developed tense bullae on her face and torso after getting the second dosage of the Pfizer-BioNTech COVID-19 Vaccine. Another case study described a 77-year-old male patient who developed generalized pruritis and bullae on erythematous bases one day after receiving the AstraZeneca COVID-19 vaccination. This new-onset bullous pemphigoid phenomenon has also been observed with other vaccinations such as rabies and swine flu. Although uncommon, several dermatological side reactions like bullous eruptions have been reported following the mRNA Pfizer Covid-19 vaccination. According to this case report, Bullous pemphigoid might be caused by the mRNA- (Pfizer) Covid-19 Vaccine.

16 June 2022 in Frontiers in Cardiovascular Medicine
Verified
Journal Article
Open access
MAMohammed AlSheef
Mohammed AlSheef
YAYacoub Abuzied
Yacoub Abuzied
MAMuteb Alosaimi
Muteb Alosaimi
AAAmer Altamimi
Amer Altamimi
QAQusai Alwazna
Qusai Alwazna
AAAmani Abu-Shaheen
Amani Abu-Shaheen
Background: Ovarian vein thrombosis (OVT) is an uncommon condition, occurring in ~1 in every 600–2,000 pregnancies. It is associated with various conditions, including thrombophilia, malignancy, sepsis, intra-abdominal and pelvic inflammatory conditions, pregnancy, and the postpartum period, and specific surgical interventions, particularly gynecological surgeries. Thus, this study aims to identify the associated factors for OVT and elaborate on the standard treatment strategies for its management.Methods: Retrospective data collection was used. Our study consists of 18 patients diagnosed with OVT between 2005 and 2016; the data was collected from the Health Information Management system at King Fahad Medical City, Riyadh, Saudi Arabia using a standard format.Results: Our study found that OVT involves the right ovarian vein more often than the left and mainly occurs in women during their postpartum period. These patients other associated factor included hypertension, diabetes, and a higher body mass index (BMI) of above 25 kg/m2. The most frequently presenting complaints were abdominal pain and fever. The most common treatment was the administration of enoxaparin (a low molecular weight heparin) for an average duration of one to three months, which resulted in a low recurrence rate of OVT.Conclusions: Physicians should be vigilant for suspicion of OVT in female patients presenting with lower abdominal pain and fever in their postpartum period. Additionally, it is suggested to use low molecular weight heparin as initial therapy for OVT for one to three months, resulting in a high remission rate.

28 October 2019 in Cureus
Verified
Journal Article
Open access
PDF file
SAsarah aljohani
sarah aljohani
MSMahmoud Salam
Mahmoud Salam
ABAla’a BaniMustafa
Ala’a BaniMustafa
Abdul Rehman Zia ZaidiAbdul Rehman Zia Zaidi
Abdul Rehman Zia Zaidi
AAAbdulaziz A Aljohani
Abdulaziz A Aljohani
MAMohammed AlSheef
Mohammed AlSheef
It is often presumed that students of health sciences are more vigilant about their diet. This study assessed the prevalence of unhealthy dietary habits and identified its associated factors among students enrolled at a large university for health sciences in the Middle East. A cross-sectional study, using a set of pre-validated and anonymous dietary tools, was conducted in 2018. The self-reported students’ characteristics and prevalence of 10 unhealthy dietary habits were collected. Males were significantly more likely have irregular meal times (β = 0.425, adjusted [adj.] odds ratio [OR] = 1.5) and insufficient seafood consumption (β = 0.55, adj. OR = 1.7) compared to females, adj. P = 0.046 and adj. P = 0.012, respectively. Students in their third year and above (β = 0.857, adj. OR = 2.2) reported more insufficient water intake compared to students in the first and second years, adjusted P = 0.003. Obesity in students was a significant associated factor with fast food consumption (β = 0.48, adj. OR = 1.8), night-eating habits (β = 0.27, adj. OR = 1.3) and skipping meals (β = 0.41, adj. OR = 1.5) compared to normal weight students, adjusted P = 0.002, adj. P = 0.004, and adj. P = 0.003, respectively. Compliance with healthy dietary habits among students was less than optimal. Special consideration should be paid to gender and obesity that have been associated with insufficient water intake, irregular meal times, skipping meals, night-eating habits, and fast food consumption.

Verified
Journal Article
Open access
PDF file
EBEbtisam Bakhsh
Ebtisam Bakhsh
mostafa shabanmostafa shaban
mostafa shaban
SSSarah Al Subaie
Sarah Al Subaie
MMMay Al Moshary
May Al Moshary
MAMohammed AlSheef
Mohammed AlSheef
Venous thromboembolism (VTE) is a common condition that can recur, leading to multiple therapeutic strategies to prevent it. The aim of this study was to explore the clinical efficacy of VTE management in Saudi Arabian hospitals and to gain insights into patient outcomes. A retrospective single-center study was conducted that retrieved the data of all patients with VTE registered from January 2015 to December 2017. Patients of all age groups were included if they attended the thrombosis clinic at KFMC during the data collection period. The study analyzed the various therapeutic strategies used for VTE and their effect on patient outcomes. The results showed that 14.6% of the patients had provoked VTE, with a higher incidence among females and younger patients. The most commonly prescribed treatment was combination therapy, followed by warfarin, oral anticoagulants, and factor Xa inhibitor. Despite being prescribed treatment, 74.9% of the patients experienced recurrence of VTE. There was no associated risk factor for recurrence in 79.9% of the patients. Thrombolytic therapy and catheter-directed thrombolysis were found to be associated with a lower risk of VTE recurrence, while anticoagulation therapy, including oral anticoagulants, was associated with a higher risk. Vitamin K antagonist (warfarin) and factor Xa inhibitor (rivaroxaban) had a significant positive association with VTE recurrence, while the use of a direct thrombin inhibitor (dabigatran) showed a lower risk, but it was not statistically significant. The results of the study highlight the need for further research to determine the most effective therapeutic strategy for VTE management in Saudi Arabian hospitals. The findings also suggest that anticoagulation therapy, including oral anticoagulants, may increase the risk of VTE recurrence, while thrombolytic therapy and catheter-directed thrombolysis may lower the risk.

1 October 2020 in Saudi Medical Journal
Verified
Journal Article
Open access
PDF file
MAMohammed AlSheef
Mohammed AlSheef
MAMastourah Alotaibi
Mastourah Alotaibi
Abdul Rehman Zia ZaidiAbdul Rehman Zia Zaidi
Abdul Rehman Zia Zaidi
AAAreej Alshamrani
Areej Alshamrani
AAAroub Alhamidi
Aroub Alhamidi
AAAmani Abu-Shaheen
Amani Abu-Shaheen
Prevalence of cerebral venous thrombosis with the use of oral contraceptive pills during the Holy month of Ramadan